Abstract
Anticyclic citrullinated peptide (anti-CCP) antibodies have been detected in patients with juvenile idiopathic arthritis (JRA), particularly in those with polyarticular JIA. We analyzed the presence of anti-CCP antibodies of the IgG class in sera of patients with defined juvenile idiopathic arthritis (JIA) of various subgroups. One hundred and fifty-nine serum samples were investigated. Forty-five patients were diagnosed with JIA (15 male and 30 female) aged 1.9–17.3 years (median 12.9, mean 11.0). Thirty-eight samples were taken from patients suffering from other autoimmunopathies and 34 patients with other underlying diseases were taken at different time points in their disease course. Under 42 samples were taken from patients with noninflammatory diseases. Enzyme-linked immunosorbent assay (ELISA) was used for the detection of anti-CCP antibodies. Anti-CCP antibodies were found in 6.9% of all samples and in 4.4% patients with JIA. Disease duration and medication did not differ significantly between anti-CCP positive and negative patients. A review of the literature and our own results shows that anti-CCP antibodies can be detected in the sera of only some patients with JIA. Routine determination of anti-CCP cannot be recommended.
Similar content being viewed by others
References
B Garcia-Berrocal C Gonzalez M Perez JA Navajo I Moreta C Davila et al. (2005) ArticleTitleAnti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients Clin Chim Acta 354 123–30 10.1016/j.cccn.2004.11.025 Occurrence Handle10.1016/j.cccn.2004.11.025 Occurrence Handle1:CAS:528:DC%2BD2MXhvVCmu7g%3D Occurrence Handle15748608
GA Schellekens H Visser BA de Jong FH van den Hoogen JM Hazes FC Breedveld et al. (2000) ArticleTitleThe diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide Arthritis Rheum 43 155–63 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3 Occurrence Handle10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3 Occurrence Handle1:CAS:528:DC%2BD3cXns1ygtg%3D%3D Occurrence Handle10643712
B Vander Cruyssen IE Hoffman H Zmierczak M Van den Berghe E Kruithof L De Rycke et al. (2005) ArticleTitleAnti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis Ann Rheum Dis 64 1145–9 10.1136/ard.2004.032177 Occurrence Handle10.1136/ard.2004.032177 Occurrence Handle1:CAS:528:DC%2BD2MXpslGmsrs%3D Occurrence Handle15695535
GA Schellekens BA de Jong FH van den Hoogen LB van de Putte WJ van Venrooij (1998) ArticleTitleCitrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies J Clin Invest 101 273–81 10.1172/JCI1316 Occurrence Handle10.1172/JCI1316 Occurrence Handle1:CAS:528:DyaK1cXjtFSjsg%3D%3D Occurrence Handle9421490
AA Rus'd Y Ikejiri H Ono T Yonekawa M Shiraiwa A Kawada et al. (1999) ArticleTitleMolecular cloning of cDNAs of mouse peptidylarginine deiminase type I, type III and type IV, and the expression pattern of type I in mouse Eur J Biochem 259 660–9 10.1046/j.1432-1327.1999.00083.x Occurrence Handle10.1046/j.1432-1327.1999.00083.x Occurrence Handle10092850
K Raza M Breese P Nightingale K Kumar T Potter DM Carruthers et al. (2005) ArticleTitlePredictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis J Rheumatol 32 231–8 Occurrence Handle1:CAS:528:DC%2BD2MXitVemtrs%3D Occurrence Handle15693082
MA van Boekel ER Vossenaar FH van den Hoogen WJ van Venrooij (2002) ArticleTitleAutoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value Arthritis Res 4 87–93 10.1186/ar395 Occurrence Handle10.1186/ar395 Occurrence Handle1:CAS:528:DC%2BD38Xhsl2rsrk%3D Occurrence Handle11879544
WJ van Venrooij JM Hazes H Visser (2002) ArticleTitleAnticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis Neth J Med 60 383–8 Occurrence Handle1:CAS:528:DC%2BD3sXms1yqurs%3D Occurrence Handle12607587
RE Petty TR Southwood J Baum E Bhettay DN Glass P Manners et al. (1998) ArticleTitleRevision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997 J Rheumatol 25 1991–4 Occurrence Handle1:STN:280:DyaK1cvltFWgtA%3D%3D Occurrence Handle9779856
P Woo LR Wedderburn (1998) ArticleTitleJuvenile chronic arthritis Lancet 351 969–73 Occurrence Handle1:STN:280:DyaK1cvgsVShtA%3D%3D Occurrence Handle9734957
JM Lawrence SuffixIII TL Moore TG Osborn G Nesher KL Madson MB Kinsella (1993) ArticleTitleAutoantibody studies in juvenile rheumatoid arthritis Semin Arthritis Rheum 22 265–74 Occurrence Handle10.1016/0049-0172(93)80074-P Occurrence Handle8484133
T Avčin R Cimaz F Falcini F Zulian G Martini G Simonini et al. (2002) ArticleTitlePrevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis Ann Rheum Dis 61 608–11 10.1136/ard.61.7.608 Occurrence Handle10.1136/ard.61.7.608 Occurrence Handle12079901
I Hromadnikova K Stechova V Pavla D Hridelova B Houbova S Voslarova et al. (2002) ArticleTitleAnti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis Autoimmunity 35 397–401 10.1080/0891693021000014970 Occurrence Handle10.1080/0891693021000014970 Occurrence Handle12568120
O Kasapçopur S Altun M Aslan S Karaarslan A Kamburoglu-Goksel S Saribas et al. (2004) ArticleTitleDiagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis Ann Rheum Dis 63 1687–9 10.1136/ard.2003.019331 Occurrence Handle10.1136/ard.2003.019331 Occurrence Handle15547097
JM Low AK Chauhan DA Kietz U Daud PH Pepmueller TL Moore (2004) ArticleTitleDetermination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis J Rheumatol 31 1829–33 Occurrence Handle1:CAS:528:DC%2BD2cXosVKls7s%3D Occurrence Handle15338508
M van Rossum R van Soesbergen S de Kort R ten Cate AH Zwinderman B de Jong et al. (2003) ArticleTitleAnti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis J Rheumatol 30 825–8 Occurrence Handle1:CAS:528:DC%2BD3sXjt12jsrY%3D Occurrence Handle12672206
J Brunner FC Sitzmann (2006) ArticleTitleThe diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis Clin Exp Rheumatol 24 449–51 Occurrence Handle1:STN:280:DC%2BD28rjt1ehtw%3D%3D Occurrence Handle16956438
N Bizzaro G Mazzanti E Tonutti D Villalta R Tozzoli (2001) ArticleTitleDiagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis Clin Chem 47 1089–93 Occurrence Handle1:CAS:528:DC%2BD3MXktFels78%3D Occurrence Handle11375296
DM Lee PH Schur (2003) ArticleTitleClinical utility of the anti-CCP assay in patients with rheumatic diseases Ann Rheum Dis 62 870–4 10.1136/ard.62.9.870 Occurrence Handle10.1136/ard.62.9.870 Occurrence Handle1:CAS:528:DC%2BD3sXns1Sisbs%3D Occurrence Handle12922961
BA Dijkmans D van Schaardenburg IE van der Horst-Bruinsma HW Reesink JP Vandenbroucke M Boers (2005) ArticleTitleThe predictive value of autoantibodies in disseminating lupus erythematosus and rheumatoid arthritis Ned Tijdschr Geneeskd 149 688–93 Occurrence Handle1:STN:280:DC%2BD2M7osFyqtA%3D%3D Occurrence Handle15819133
D Us D Gulmez G Hascelik (2003) ArticleTitleCyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis Mikrobiyol Bul 37 163–70 Occurrence Handle14593899
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Brunner, J., Sitzmann, F. Anticyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Mod Rheumatol 16, 372–375 (2006). https://doi.org/10.1007/s10165-006-0520-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10165-006-0520-4